MKI67 and breast cancer: This was confirmed in this current study, where HIV-infected breast cancer patients were significantly younger (median age 49.0 (43.0–56.5) and 53.0 (46.0–72.0), respectively; p = 0.054) and had a higher Ki67 proliferative index.